Clinical Trials Browser

Neoplasms, Nerve Tissue, Neurofibromatosis 1, Peripheral Nervous System Diseases, Neurofibroma, Plexiform, Heredodegenerative Disorders, Nervous System

NCT01490476 2017-05-23

AFINF2

Phase 2 Completed

10 enrolled

CNS

Vestibulocochlear Nerve Diseases, Neuroma, Acoustic, Otorhinolaryngologic Diseases, Peripheral Nervous System Diseases, Neurofibromatosis 2

NCT00952848 2017-03-29

Electrical Stimulation Therapy Using the MC5-A Scrambler in Reducing Peripheral Neuropathy Caused by Chemotherapy

Phase 2 Completed

18 enrolled 10 charts

Pain, Peripheral Nervous System Diseases, Neurotoxicity Syndromes

NCT00891618 2016-10-31

Acupuncture for Chemo-Induced Peripheral Neuropathy

Phase 2 Completed

27 enrolled 3 charts

LymphoidPlasma cell

Lymphoma, Lymphoma, Non-Hodgkin, Multiple Myeloma, Peripheral Nervous System Diseases, Neoplasms, Plasma Cell

NCT00365768 2016-09-09

Glutamine in Treating Neuropathy Caused by Vincristine in Young Patients With Lymphoma, Leukemia, or Solid Tumors

Phase 2 Completed

56 enrolled 5 charts

GenitourinaryLymphoidOther hematologic neoplasmSarcoma

Burkitt Lymphoma, Kidney Neoplasms, Leukemia, Lymphoma, Wilms Tumor, Peripheral Nervous System Diseases, Sarcoma, Lymphoma, Large B-Cell, Diffuse, Neuroectodermal Tumors, Primitive, Peripheral, Neurotoxicity Syndromes, Lymphoma, Extranodal NK-T-Cell, Dendritic Cell Sarcoma, Interdigitating

NCT01278004 2016-05-26

CINE-E

Phase 2 Completed

15 enrolled

Neoplasms, Peripheral Nervous System Diseases

NCT02230319 2015-10-01

Prevention of Paclitaxel Neuropathy With Cryotherapy

Phase 2 Unknown

39 enrolled

Breast

Breast Neoplasms, Peripheral Nervous System Diseases

NCT00267007 2014-06-04

A Study to Investigate the Neuroprotective Effect of PROCRIT (Epoetin Alfa) Versus Placebo in Cancer Patients Who Develop Chemotherapy-induced Peripheral Neuropathy

Phase 2 Terminated

32 enrolled 9 charts

Neoplasms, Peripheral Nervous System Diseases

NCT00041795 2005-06-24

Neotrofin for Treatment of Chemotherapy-Induced Peripheral Neuropathy

Phase 2 Completed

50 enrolled

Peripheral Nervous System Diseases

Clinical Trials

DETOXp

o Tadalafil for Prevention of Docetaxel-Induced Peripheral Neuropathy in Prostate Cancer

PT-112 in Subjects With Thymoma and Thymic Carcinoma

NIAGEN and Persistent Chemotherapy-Induced Peripheral Neuropathy

Prevention of Paclitaxel-induced Peripheral Neuropathy in Breast Cancer Patients

A Study of Topical Pirenzepine or Placebo in Oncology Patients With Chemotherapy Induced Peripheral Neuropathy

Evaluation of Hydroxychloroquine to Prevent CIPN

Efficacy of Metformin as Preventive Treatment in Paclitaxel Induced Peripheral Neuropathy in Breast Cancer Patients

Prevention of Taxane-associated Acute Pain Syndrome With Etoricoxib

Minocycline Hydrochloride in Reducing Chemotherapy-Induced Peripheral Neuropathy and Acute Pain in Patients With Breast Cancer Undergoing Treatment With Paclitaxel

Glutamine in Preventing Peripheral Neuropathy in Patients With Multiple Myeloma Receiving Bortezomib

CIPN

Mitogen Activated Protein Kinase Kinase (MEK1/2) Inhibitor Selumetinib (AZD6244 Hydrogen Sulfate) in People With Neurofibromatosis Type 1 (NF1) Mutated Gastrointestinal Stromal Tumors (GIST)

AFINF2

Electrical Stimulation Therapy Using the MC5-A Scrambler in Reducing Peripheral Neuropathy Caused by Chemotherapy

Acupuncture for Chemo-Induced Peripheral Neuropathy

Glutamine in Treating Neuropathy Caused by Vincristine in Young Patients With Lymphoma, Leukemia, or Solid Tumors

CINE-E

Prevention of Paclitaxel Neuropathy With Cryotherapy

A Study to Investigate the Neuroprotective Effect of PROCRIT (Epoetin Alfa) Versus Placebo in Cancer Patients Who Develop Chemotherapy-induced Peripheral Neuropathy

Neotrofin for Treatment of Chemotherapy-Induced Peripheral Neuropathy